A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
作者： J. A. Cramer , D. T. Gold , S. L. Silverman , E. M. Lewiecki
DOI: 10.1007/S00198-006-0322-8
关键词: Medicine 、 Surgery 、 Compliance (physiology) 、 Rheumatology 、 Alternative medicine 、 Intensive care medicine 、 Hormone replacement therapy (menopause) 、 Internal medicine 、 Bisphosphonate therapy 、 MEDLINE 、 Persistence (computer science) 、 Osteoporosis
摘要: Summary Fourteen reports utilizing data from de-identified administrative databases were reviewed. Studies contained at least one measure of patient persistence or compliance with bisphosphonates and other anti-osteoporosis medications. These studies confirm that women osteoporosis have suboptimal rates bisphosphonate therapy.
springer.com
sci-hub.se 参考文章(33)
Joyce A. Cramer, Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence. The American Journal of Managed Care. ,vol. 4, pp. 1563- ,(1998)
Ada Tamir, Elena Segal, Sophia Ish-Shalom, Compliance of osteoporotic patients with different treatment regimens. Israel Medical Association Journal. ,vol. 5, pp. 859- 862 ,(2003)
AN Tosteson, Margaret R Grove, Cristina S Hammond, Megan M Moncur, G Thomas Ray, Gwen M Hebert, Alice R Pressman, Bruce Ettinger, Early discontinuation of treatment for osteoporosis. The American Journal of Medicine. ,vol. 115, pp. 209- 216 ,(2003) , 10.1016/S0002-9343(03)00362-0
Dorothy A. Nelson, Robert Molloy, Michael Kleerekoper, Prevalence of Osteoporosis in Women Referred for Bone Density Testing: Utility of Multiple Skeletal Sites Journal of Clinical Densitometry. ,vol. 1, pp. 5- 11 ,(1998) , 10.1385/JCD:1:1:5
Pierre D. Delmas, Silvano Adami, Cezary Strugala, Jacob A. Stakkestad, Jean-Yves Reginster, Dieter Felsenberg, Claus Christiansen, Roberto Civitelli, Marc K. Drezner, Robert R. Recker, Michael Bolognese, Claire Hughes, Daiva Masanauskaite, Penelope Ward, Philip Sambrook, David M. Reid, Intravenous Ibandronate Injections in Postmenopausal Women With Osteoporosis One-Year Results From the Dosing Intravenous Administration Study Arthritis & Rheumatism. ,vol. 54, pp. 1838- 1846 ,(2006) , 10.1002/ART.21918
Ami J. Claxton, Joyce Cramer, Courtney Pierce, A systematic review of the associations between dose regimens and medication compliance Clinical Therapeutics. ,vol. 23, pp. 1296- 1310 ,(2001) , 10.1016/S0149-2918(01)80109-0
J. C. Lo, A. R. Pressman, M. A. Omar, B. Ettinger, Persistence with weekly alendronate therapy among postmenopausal women Osteoporosis International. ,vol. 17, pp. 922- 928 ,(2006) , 10.1007/S00198-006-0085-2
M. Rossini, G. Bianchi, O. Di Munno, S. Giannini, S. Minisola, L. Sinigaglia, S. Adami, Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporosis International. ,vol. 17, pp. 914- 921 ,(2006) , 10.1007/S00198-006-0073-6
James Nairus, Sadri Ahmadi, Stephen Baker, Daniel Baran, Quantitative Ultrasound: An Indicator of Osteoporosis in Perimenopausal Women Journal of Clinical Densitometry. ,vol. 3, pp. 141- 147 ,(2000) , 10.1385/JCD:3:2:141
Mark P. Ettinger, Rich Gallagher, Paul E. MacCosbe, Medication persistence with weekly versus daily doses of orally administered bisphosphonates Endocrine Practice. ,vol. 12, pp. 522- 528 ,(2006) , 10.4158/EP.12.5.522